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Thank you for your pointing out some potential discrepancy 
that some well known thyroid cancer cell lines are not derived 
from thyroid cell origin in our recent study (1). Schweppe et al. 
(2) evaluated 40 reported thyroid cancer-derived cell lines us-
ing short tandem repeat (STR) and single nucleotide polymor-
phism (SNP) array analysis. They found some misidentified cell 
lines in August 2008; the ARO matched the HT-29 colon cancer 
cell line, and the NPA matched the the M14/MD-MB-435S mel-
anoma cell line (2). 
  In this report, they already admitted that STR or SNP profil-
ing did not provide any information regarding tissue origin and 
the result of their study was due to cross-contamination of cell 
lines.
  Actually we started our study from 2004, four years earlier that 
the submission date of paper from Schweppe et al. and thyroid 
cancer cell lines (NPA, FRO, ARO) were kindly donated by Dr. 
Shong, who reported several good articles using these undiffer-
entiated, anaplastic thyroid cancer cell lines which are his ma-
jor concern of interest (3). We did not deal with cancer cell lines 
other than F9, thyroid cancer cell lines at that time. Therefore, 
we thought that our cells were not cross-contaminated with can-
cer cell lines derived from other cell origin. 
  In the article of Scheweppe et al. (2), they reported that NPA 
was identical to M14 cell line and MBA-MB-435S cell line. Be-
fore mentioning about the relation between NPA cells and M14/ 
MBA-MB-435S cells, the M14 cell line was not identical to the 
MBA-MB-435S cell which Hollestelle A and Schutte M (4) re-
vealed in 2009. The M14 cell was originated from human male 
melanoma and MBA-MB-435S was originated from human fe-
male breast cancer. M14/MBA-MB-435S cells have been report-
ed to express only heterozygous BRAF V600E mutations, but 
NPA cells showed homo/heterozygous BRAF V600E mutations 
by Scheweppe et al. (2), and they suggested that the difference 
was due to LOH occurred during culturing. Likewise, ARO cells 
have been reported to express homo/hemizygous or heterozy-
gous BRAF mutations, but HT-29 cells showed only heterozygous 
mutation by Scheweppe et al. (2). Therefore, the report that the 
NPA cell is identical to M14/MBA-MB-435S cell and ARO cell is 
identical to HT-29 cell was based on their suggestions not on 
true scientific data.
  In conclusion, we insist that the NPA or ARO cells used for 
our study are of true thyroid undifferentiated, anaplstic thyroid 
cancer cell origin, and the claims by Scheweppe et al. (2) are due 
to cross-contaminations during cell passages in the laboratory 
as they described. 
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